• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 HAYES, Inc. Cologuard
2014 HAYES, Inc. Cytochrome P450 genotyping to predict response to opioid pain medications
2014 HAYES, Inc. Duchenne/Becker muscular dystrophy (DMD/BMD)
2014 HAYES, Inc. Genetic testing for Lynch syndrome
2014 HAYES, Inc. Prosigna breast cancer prognostic gene signature assay
2014 HAYES, Inc. Screening for Lynch syndrome
2014 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness and efficacy of minimally invasive lung volume reduction surgery for emphysema]
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Acupuncture - areas of application, current evidence and proven indications]
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Opportunities and strategies to drive appropriate use of MRI in Austria
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Idelalisib (Zydelig(R)) in addition to rituximab for the treatment of relapsed chronic lymphocytic leukaemia
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vasoprotectives: efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [High-dose rate brachytherapy in the treatment of mobile tongue cancer]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Sialendoscopy for the management of obstructive salivary gland disease]
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force
2014 Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable cardiac resyncronization therapy and defibrillator (CRT-D) in patient with heart failure
2014 Medical Services Advisory Committee (MSAC) Cone beam computer tomography (CBCT) for dental/craniofacial imaging
2014 Medical Services Advisory Committee (MSAC) Oncotype DX® breast cancer assay to quantify the risk of disease recurrence and predict adjuvant hemotherapy benefit
2014 Medical Services Advisory Committee (MSAC) National Cervical Screening Program renewal
2014 Medical Services Advisory Committee (MSAC) Radium 223 for the treatment of patients with symptomatic castrate resistant prostate cancer with skeletal metastases
2014 Medical Services Advisory Committee (MSAC) HbA1c test for the diagnosis of diabetes mellitus
2014 Medical Services Advisory Committee (MSAC) Catheter-free ambulatory pH test for Gastroesophageal Reflux Disease (GORD)
2014 Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices
2014 Medical Services Advisory Committee (MSAC) The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques
2014 Medical Services Advisory Committee (MSAC) Magnetic Resonance Imaging (MRI) for small bowel and pelvis in Crohn disease
2014 Medical Services Advisory Committee (MSAC) Intensive Care Medicine consultation items
2014 Medical Services Advisory Committee (MSAC) Palliative care consultation items
2014 Medical Services Advisory Committee (MSAC) Review of interim funded service: breast Magnetic Resonance Imaging (MRI)
2014 Medical Services Advisory Committee (MSAC) IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb
2014 Medical Services Advisory Committee (MSAC) RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients.
2014 Medical Services Advisory Committee (MSAC) Resubmission Cetuximab and RAS testing under MBS 73330
2014 Blue Cross Blue Shield Association (BCBS) Special report: medication adherence
2014 Blue Cross Blue Shield Association (BCBS) Bronchial thermoplasty for treatment of inadequately controlled severe asthma
2014 Blue Cross Blue Shield Association (BCBS) Endovascular treatments for acute ischemic stroke in adults
2014 Blue Cross Blue Shield Association (BCBS) Cost-effectiveness studies of new hepatitis C treatments
2014 University of York Value based commissioning of MSK Procedures: an appraisal of the evidence for the proposed policies
2014 University of York Effects of lay-led self-care education programmes
2014 University of York Interventions to reduce unplanned admissions from care home settings
2014 University of York Housing improvement and home safety
2014 Norwegian Knowledge Centre for the Health Services (NOKC) [Effects of using social media in health awareness campaigns to promote healthy lifestyle habits]
2014 HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2014 HTA Unit, University of Calgary Best practices in the management of behavioural and psychological symptoms of dementia in residents of long-term care facilities in Alberta
2014 Adelaide Health Technology Assessment (AHTA) An assessment of nucleic acid amplification testing for active mycobacterial infection
2014 Penn Medicine Center for Evidence-based Practice (CEP) Update: Cognitive and procedural skills of aging physicians
2014 Penn Medicine Center for Evidence-based Practice (CEP) Rehydration, anti-diarrheal, and anti-emetic therapy for patients with Ebola virus disease
2014 Penn Medicine Center for Evidence-based Practice (CEP) Interventions to expedite administration of antibiotics
2014 Penn Medicine Center for Evidence-based Practice (CEP) Advance care planning in the outpatient oncology setting
2014 Penn Medicine Center for Evidence-based Practice (CEP) Models of physician employment/affiliation after an AMC-Community Hospital merger
2014 Penn Medicine Center for Evidence-based Practice (CEP) Management of intraductal papilloma of the breast
2014 Penn Medicine Center for Evidence-based Practice (CEP) Conceptual models of continuity: current perspectives
2014 Penn Medicine Center for Evidence-based Practice (CEP) Calmare for chemotherapy-induced peripheral neuropathy
2014 Penn Medicine Center for Evidence-based Practice (CEP) Supplemental oxygen therapy for patients with acute myocardial infarction
2014 Penn Medicine Center for Evidence-based Practice (CEP) Oral versus intravenous antibiotics for pediatric oncology patients with fever
2014 Penn Medicine Center for Evidence-based Practice (CEP) Management of geriatric depression identified in the acute care setting
2014 Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography
2014 Penn Medicine Center for Evidence-based Practice (CEP) Impact of physician specialty and hospital models of care on healthcare utilization in patients with sickle cell disease
2014 Penn Medicine Center for Evidence-based Practice (CEP) Interventions to reduce stress among nurses caring for patients with sickle cell disease
2014 Penn Medicine Center for Evidence-based Practice (CEP) Patient-controlled analgesia for management of acute sickle cell disease
2014 Penn Medicine Center for Evidence-based Practice (CEP) Safety of renal biopsy for patients taking aspirin
2014 Penn Medicine Center for Evidence-based Practice (CEP) Risk factors for high resource utilization in patients with sickle cell disease
2014 Penn Medicine Center for Evidence-based Practice (CEP) Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2014 Penn Medicine Center for Evidence-based Practice (CEP) Allocating nursing personnel across units: shift-to-shift staffing
2014 Medical Services Advisory Committee (MSAC) Insertion of subcutaneous electrode for the purpose of use with an implantable cardioverter defibrillator (ICD)
2014 Medical Services Advisory Committee (MSAC) Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole
2014 Medical Services Advisory Committee (MSAC) Specialist dermatology services delivered by asynchronous store and forward technology
2014 Medical Services Advisory Committee (MSAC) Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2014 Medical Services Advisory Committee (MSAC) Second Opinion for Morphological/Interpretive Pathology
2014 Medical Services Advisory Committee (MSAC) Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
2014 Medical Services Advisory Committee (MSAC) The removal of imbedded corneal foreign bodies by an optometrist
2014 Medical Services Advisory Committee (MSAC) Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
2014 Medical Services Advisory Committee (MSAC) Non-mydriatic retinal photography (NMP) in persons with diabetes
2014 Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices (resubmission)
2014 Medical Services Advisory Committee (MSAC) Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
2014 Health Council of the Netherlands Gezondheidsraad (GR) Penicillamine - Evaluation of the effects on reproduction, recommendation for classification
2014 Health Council of the Netherlands Gezondheidsraad (GR) 5-Nitroacenaphthene
2014 Health Council of the Netherlands Gezondheidsraad (GR) Mobile phones and cancer. Part 2. Animal studies on carcinogenesis
2014 Health Council of the Netherlands Gezondheidsraad (GR) Dimethyl sulphate. Health-based calculated occupational cancer risk values
2014 Health Council of the Netherlands Gezondheidsraad (GR) Fungal alpha-amylase (derived from the fungus Aspergillus oryzae)
2014 Health Council of the Netherlands Gezondheidsraad (GR) Acetaldehyde. Re-evaluation of the carcinogenicity and genotoxicity
2014 Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive requirements: some recommendations
2014 Health Council of the Netherlands Gezondheidsraad (GR) Employees and infectious diseases - criteria for vaccination
2014 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: first trimester scan for prenatal screening
2014 Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: study into self-sampling as primary screening for cervical cancer
2014 NIHR Health Technology Assessment programme Interventions for central serous retinopathy: a network meta-analysis
2014 NIHR Health Technology Assessment programme Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism [ID726]
2014 NIHR Health Technology Assessment programme Aflibercept solution for injection for treating diabetic macular oedema [ID717]
2014 NIHR Health Technology Assessment programme Dexamethasone intravitreal implant for treating diabetic macular oedema [ID653]
2014 NIHR Health Technology Assessment programme Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]
2014 Institute of Health Economics (IHE) Low dose computed tomography for the screening of lung cancer in adults
2014 Institute of Health Economics (IHE) First and second trimester prenatal screening update
2014 Institute of Health Economics (IHE) Endovenous ablation interventions for symptomatic varicose veins of the legs
2014 Institute of Health Economics (IHE) Hysteroscopic tubal sterilization
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Miethke proSA® adjustable gravitational shunt for hydrocephalus
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness